Abigail Johnson of Fidelity reaches deal to avoid testifying at 401(k) trial

Abigail Johnson of Fidelity reaches deal to avoid testifying at 401(k) trial
The parties in the MIT 401(k) suit negotiated an agreement that spares Ms. Johnson from having to undergo cross-examination.
SEP 06, 2019
Abigail Johnson, chairman and chief executive of Fidelity Investments, will not have to testify at an upcoming trial regarding the Massachusetts Institute of Technology 401(k) plan, marking a stark de-escalation of tensions that had flared in recent weeks amid allegations the executive was engaged in a quid pro quo arrangement with the university's retirement plan. Plaintiffs had sought Ms. Johnson's testimony in a trial scheduled for Sep. 15 in a suit that alleges the university retained Fidelity's 401(k) services with the expectation that, in return, Ms. Johnson and Fidelity would make a large donation to the university. [Recommended video: Retirement advisers can boost business by focusing on participants in these ways] Plaintiffs, represented by attorney Jerome Schlichter, claim the school breached its fiduciary duties by retaining costly record-keeping and investment management services from Fidelity. They allege the partnership between MIT and Fidelity resulted in the university securing more than $23 million in donations from Fidelity since it became record keeper. Fidelity fired back, saying in a late-August court filing that the effort to have Ms. Johnson testify amounted to a "transparent attempt to harass Ms. Johnson and to attract media attention." Mr. Schlichter subsequently called that assertion "illogical." Neither Fidelity nor Ms. Johnson are defendants in the lawsuit, Tracey et al v. Massachusetts Institute of Technology. Ms. Johnson is a member of MIT's board of trustees, However, plaintiffs removed Ms. Johnson from their witness list after "extensive negotiations," according to a filing Thursday in Massachusetts district court. The parties agreed, in return, to "stipulate to certain facts that may be presented to the court during trial." This agreement means defendants can't object to certain evidence that the plaintiffs introduce during the trial, said Roger Levy, who has served as an expert witness in past retirement-plan litigation, including cases against American Century Investments and Anthem Inc. Such evidence could include testimony Ms. Johnson would have provided at trial anyway. Ms. Johnson may have preferred not to testify in order to avoid cross-examination, Mr. Levy speculated. "We will use the stipulation to demonstrate the facts we allege, and we don't need her testimony to do that now," Mr. Schlichter said, referring to Ms. Johnson. James Carroll, an attorney representing Fidelity and Ms. Johnson, didn't respond to a request for comment by press time.

Latest News

NASAA moves to let state RIAs use client testimonials, aligning with SEC rule
NASAA moves to let state RIAs use client testimonials, aligning with SEC rule

A new proposal could end the ban on promoting client reviews in states like California and Connecticut, giving state-registered advisors a level playing field with their SEC-registered peers.

Could 401(k) plan participants gain from guided personalization?
Could 401(k) plan participants gain from guided personalization?

Morningstar research data show improved retirement trajectories for self-directors and allocators placed in managed accounts.

UBS sees a net loss of 111 financial advisors in the Americas during the second quarter
UBS sees a net loss of 111 financial advisors in the Americas during the second quarter

Some in the industry say that more UBS financial advisors this year will be heading for the exits.

JPMorgan reopens fight with fintechs, crypto over fees for customer data
JPMorgan reopens fight with fintechs, crypto over fees for customer data

The Wall Street giant has blasted data middlemen as digital freeloaders, but tech firms and consumer advocates are pushing back.

The average retiree is facing $173K in health care costs, Fidelity says
The average retiree is facing $173K in health care costs, Fidelity says

Research reveals a 4% year-on-year increase in expenses that one in five Americans, including one-quarter of Gen Xers, say they have not planned for.

SPONSORED How advisors can build for high-net-worth complexity

Orion's Tom Wilson on delivering coordinated, high-touch service in a world where returns alone no longer set you apart.

SPONSORED RILAs bring stability, growth during volatile markets

Barely a decade old, registered index-linked annuities have quickly surged in popularity, thanks to their unique blend of protection and growth potential—an appealing option for investors looking to chart a steadier course through today's choppy market waters, says Myles Lambert, Brighthouse Financial.